THOUSAND OAKS,
Calif., May 10,
2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will
present at the Bank of America Merrill Lynch 2019
Health Care Conference at 10 a.m. PT on Wednesday, May 15, 2019. David W. Meline, executive vice president and
chief financial officer at Amgen, will present at the conference.
Live audio of the presentation can be accessed from
the Events Calendar on Amgen's website,
www.amgen.com, under Investors. A replay of the
webcast will also be available on Amgen's website for at least 90
days following the event.
About Amgen
Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and
leverages its expertise to strive for solutions that improve health
outcomes and dramatically improve people's lives. A biotechnology
pioneer since 1980, Amgen has grown to be one of the world's
leading independent biotechnology companies, has reached millions
of patients around the world and is developing a pipeline of
medicines with breakaway potential.
For more information, visit
www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Jessica Akopyan, 805-447-0974
(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-bank-of-america-merrill-lynch-2019-health-care-conference-300848308.html
SOURCE Amgen